A reply to Moris et al
- PMID: 36134554
- DOI: 10.1002/ajh.26738
A reply to Moris et al
Comment on
-
A comment on: "Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial".Am J Hematol. 2022 Dec;97(12):E482-E483. doi: 10.1002/ajh.26740. Epub 2022 Oct 7. Am J Hematol. 2022. PMID: 36149779 No abstract available.
References
REFERENCE
-
- Moris W, Koek GH, Van Deursen C. A comment on: Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial. Am J Hematol.
Publication types
LinkOut - more resources
Full Text Sources
